Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
huc-MSCs for Ischemic-type Biliary Lesions After Liver Transplantation
NCT02223897Phase 3Unknown
- Start
- Jul 2014
- Primary completion
- Jun 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of human umbilical cord mesenchymal stem cells in ischemic-type biliary lesions (ITBL). Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
ischemic-type biliary lesions (ITBL)
Beyond the preview
Go deeper on NCT02223897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02223897.